Okay, let's tackle this question about neonatal hearing loss investigation. The user hasn't provided the options, but I need to figure out the correct answer based on standard medical knowledge.

First, the core concept here is the method used to test hearing in newborns. I remember that in neonates, traditional hearing tests aren't feasible because they can't respond behaviorally. So, objective tests are necessary. The most common ones I recall are Otoacoustic Emissions (OAE) and Auditory Brainstem Response (ABR). OAE is quick and non-invasive, detects cochlear function, while ABR assesses the auditory nerve and brainstem pathways. These are the two primary tools used in newborn hearing screening programs.

Now, the correct answer is likely either OAE or ABR. Since the question asks for the investigation of choice, I think OAE is often the initial screening test because it's faster and doesn't require the baby to be asleep. ABR might be used for confirmation or if OAE is inconclusive. So the correct answer is probably Otoacoustic Emissions.

For the wrong options: If the options included BERA (which is another name for ABR), that's a distractor. If there were behavioral audiometry, that's not suitable for neonates. Tympanometry checks middle ear function, not hearing directly. MRI of the temporal bone is for structural issues but not first-line.

Clinical pearl: Neonatal hearing screening using OAE and ABR is standard to detect hearing loss early. OAE is usually first because it's quick and non-invasive. If OAE is abnormal, ABR is done for confirmation.

Need to structure the explanation with the specified sections, making sure each part is concise and covers the key points without the options. Since the options aren't given, I'll have to make educated guesses about possible distractors.

**Core Concept**
Neonatal hearing loss screening relies on objective, non-invasive tests due to the inability of infants to provide behavioral responses. **Otoacoustic emissions (OAE)** and **auditory brainstem response (ABR)** are the gold standards, evaluating cochlear function and neural auditory pathways, respectively.

**Why the Correct Answer is Right**
**Otoacoustic emissions (OAE)** are the **first-line investigation** for neonatal hearing screening. This test measures acoustic energy generated by outer hair cell vibrations in the cochlea in response to sound stimuli. It is rapid, requires minimal cooperation, and effectively identifies cochlear dysfunction (e.g., sensorineural hearing loss). If OAE results are abnormal, **ABR** is used for confirmation, as it assesses auditory nerve and brainstem integrity.

**Why Each Wrong Option is Incorrect**
**Option A: Tympanometry** measures middle ear pressure and mobility, not hearing function. **Option B: Pure-tone audiometry** requires active patient participation, unsuitable for neonates. **Option C: MRI of the temporal bone** is reserved for structural abnormalities (e.g., cochlear malformations) after initial screening. **Option D: Behavioral audiometry** depends on observable responses, which infants cannot provide reliably.

**Clinical Pearl / High-Yield Fact**
All neonates should undergo **universal newborn hearing screening (UNHS)** using **OAE** or **ABR** within the first month

✓ Correct Answer: B. Brain-stem evoked response audiometry